학술논문
4B.03
Document Type
Article
Source
Journal of Hypertension; June 2015, Vol. 33 Issue: Supplement 1 pe53-e53, 1p
Subject
Language
ISSN
02636352; 14735598
Abstract
To assess changes in systolic blood pressure (SBP) with empagliflozin in patients with type 2 diabetes and hypertension (defined as mean seated office SBP 130–159 mmHg and diastolic BP 80–99 mmHg) categorised as dippers or non-dippers.